type-1

Documents about type-1

• Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)#343774ClinicalTrials.gov
• Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes#363573ClinicalTrials.gov
• The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus#369971ClinicalTrials.gov
• Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes#394705ClinicalTrials.gov
• Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes#394721ClinicalTrials.gov
• A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes#407837ClinicalTrials.gov
• Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients#407843ClinicalTrials.gov
• Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus#407855ClinicalTrials.gov
• A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes#417514ClinicalTrials.gov
• European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.#300378ClinicalTrials.gov
• To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.#432849ClinicalTrials.gov
• Breakfast Nutrition and Inpatient Glycemia#257036ClinicalTrials.gov
• SweMaMi DMI, Microbiome#414400ClinicalTrials.gov
• Diet, gut microbiome, and type 1 diabetes: from risk to translational opportunity#4741Europe PMC
• The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1#123621ClinicalTrials.gov
• Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes#123636ClinicalTrials.gov
• Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus#127779ClinicalTrials.gov
• Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes#136251ClinicalTrials.gov
• Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years#143730ClinicalTrials.gov
• Evaluation of the Association Between Depression and Glycemic Control in People With Type 1 Diabetes#249546ClinicalTrials.gov
• Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis#267961ClinicalTrials.gov
• Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 Diabetes#272276ClinicalTrials.gov
• Hypoglycaemia and Cardiac Arrhythmias in Type 1 Diabetes#283195ClinicalTrials.gov
• Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration#287453ClinicalTrials.gov
• Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya.#329445ClinicalTrials.gov
• The Management of Glucose Control and Hypoglycemic Prevention Using Continuous Glucose Monitoring System in Patients With Type 1 Diabetes#329466ClinicalTrials.gov
• Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose#363550ClinicalTrials.gov
• Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes#363557ClinicalTrials.gov
• A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)#373745ClinicalTrials.gov
• Web-based Support During Pregnancy and Early Motherhood in Women With Type 1 Diabetes (MODIAB-web)#424325ClinicalTrials.gov
• A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes#435676ClinicalTrials.gov
• Stereoselective Synthesis of the Gal‐α‐(1→3)‐Gal‐β‐(1→3)‐GlcNAc Trisaccharide: a new Ligand for DCAR and Mincle C‐Type Lectin Receptors#250580IRIS
• Metronom Continuous Glucose Monitoring System#127774ClinicalTrials.gov
• Family-Based Treatment for Type 1 Diabetes#121239ClinicalTrials.gov
• Influence of Aerobic Exercise and HIIT on Glycemic Control in Adult Men With Type 1 Diabetes (TAILOR/1b)#136216ClinicalTrials.gov
• Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet#152366ClinicalTrials.gov
• Do People With Complications of Type 1 Diabetes Mellitus Have a Different Microbiome (MARVEL)#158117ClinicalTrials.gov
• Glycemic Response to Carbob-Enriched Pasta in Healthy and With Type 1 Diabetes People#180281ClinicalTrials.gov
• Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years#249540ClinicalTrials.gov
• A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes#253155ClinicalTrials.gov
• Ultrasound Classification and Grading of Lipohypertrophy and Its Impact on Glucose Variability in Type 1 Diabetes#279643ClinicalTrials.gov
• A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus#290927ClinicalTrials.gov
• Clinical Utility of Tight Objectives of Advanced Hybrid Closed-loop Systems Among Type 1 Diabetes Patients (TightT1AHCL)#303666ClinicalTrials.gov
• A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus#314275ClinicalTrials.gov
• A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes#321630ClinicalTrials.gov
• Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes Mellitus#325214ClinicalTrials.gov
• Effects of Web-Based Health Information on Risk Behavior for Youth With Type 1 Diabetes in College#353406ClinicalTrials.gov
• A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes#353418ClinicalTrials.gov
• Living Well With Type 1 Diabetes in Middle School: A Student‐Centered Perspective#226985HAL (France)
• CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)#414454ClinicalTrials.gov